ConforMIS Company Profile (NASDAQ:CFMS)


ConforMIS logoConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Devices & Implants
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CFMS
  • CUSIP: N/A
  • Web:
  • Market Cap: $194.7 million
  • Outstanding Shares: 43,850,000
Average Prices:
  • 50 Day Moving Avg: $4.22
  • 200 Day Moving Avg: $5.65
  • 52 Week Range: $3.79 - $10.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.78
  • P/E Growth: 0.25
Sales & Book Value:
  • Annual Revenue: $80.1 million
  • Price / Sales: 2.50
  • Book Value: $1.82 per share
  • Price / Book: 2.51
  • EBIDTA: ($55,080,000.00)
  • Net Margins: -74.55%
  • Return on Equity: -60.57%
  • Return on Assets: -50.04%
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 6.13%
  • Quick Ratio: 5.37%
  • Average Volume: 281,854 shs.
  • Beta: 2.15
  • Short Ratio: 11.91

Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS, Inc. (NASDAQ:CFMS) announced its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.04. The business earned $20.50 million during the quarter, compared to the consensus estimate of $18.48 million. ConforMIS had a negative net margin of 74.55% and a negative return on equity of 60.57%. ConforMIS's revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.37) EPS. View ConforMIS's Earnings History.

Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?

6 equities research analysts have issued 1 year target prices for ConforMIS's shares. Their predictions range from $7.50 to $14.00. On average, they anticipate ConforMIS's share price to reach $9.90 in the next twelve months. View Analyst Ratings for ConforMIS.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:

  • Kenneth Fallon III, Independent Chairman of the Board
  • Mark A. Augusti, President, Chief Executive Officer, Director
  • Paul S. Weiner, Chief Financial Officer
  • Daniel Steines M.D., Chief Technology Officer
  • David Cerveny, Chief Legal Officer and General Counsel
  • Philipp Lang M.D., Director
  • Bradley R. Langdale, Independent Director
  • Colm C. Lanigan, Independent Director
  • Richard J. Meelia, Independent Director
  • Michael D. Milligan, Independent Director

When did ConforMIS IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who owns ConforMIS stock?

ConforMIS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Creative Planning (0.06%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.

Who sold ConforMIS stock? Who is selling ConforMIS stock?

ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Creative Planning. Company insiders that have sold ConforMIS stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.

How do I buy ConforMIS stock?

Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of ConforMIS stock can currently be purchased for approximately $4.57.

MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  108 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ConforMIS (NASDAQ:CFMS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.90 (116.63% upside)

Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/16/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
6/20/2017Oppenheimer Holdings, Inc.Reiterated RatingBuyLowView Rating Details
5/16/2017B. RileyReiterated RatingBuy$7.50LowView Rating Details
5/11/2017Canaccord GenuitySet Price TargetHold$8.00LowView Rating Details
11/4/2016J P Morgan Chase & CoReiterated RatingHold$11.00N/AView Rating Details
9/19/2016SunTrust Banks, Inc.Initiated CoverageBuy$14.00N/AView Rating Details
5/13/2016Deutsche Bank AGLower Price TargetBuy$26.00 -> $12.00N/AView Rating Details
5/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/1/2015Sterne Agee CRTInitiated CoverageBuy$26.00N/AView Rating Details
(Data available from 7/20/2015 forward)


Earnings History for ConforMIS (NASDAQ:CFMS)
Earnings by Quarter for ConforMIS (NASDAQ:CFMS)
Earnings History by Quarter for ConforMIS (NASDAQ CFMS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q1 2017($0.36)($0.40)$18.48 million$20.50 millionViewN/AView Earnings Details
2/15/2017Q416($0.30)($0.37)$21.37 million$21.70 millionViewListenView Earnings Details
11/3/2016Q316($0.36)($0.31)$18.27 million$18.60 millionViewListenView Earnings Details
8/8/2016Q216($0.35)($0.34)$18.02 million$19.30 millionViewListenView Earnings Details
5/12/2016Q116($0.38)($0.37)$19.23 million$20.30 millionViewListenView Earnings Details
2/11/2016Q415($0.41)($0.37)$17.23 million$19.10 millionViewListenView Earnings Details
11/2/2015Q3($0.38)($0.45)$13.51 million$13.90 millionViewN/AView Earnings Details
8/11/2015Q215($1.31)($2.51)$11.20 million$19.20 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ConforMIS (NASDAQ:CFMS)
2017 EPS Consensus Estimate: ($1.44)
2018 EPS Consensus Estimate: ($1.36)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.38)($0.36)($0.37)
Q2 20173($0.39)($0.35)($0.37)
Q3 20173($0.37)($0.33)($0.35)
Q4 20173($0.36)($0.34)($0.35)
Q1 20181($0.34)($0.34)($0.34)
Q2 20181($0.34)($0.34)($0.34)
Q3 20181($0.34)($0.34)($0.34)
Q4 20181($0.34)($0.34)($0.34)
(Data provided by Zacks Investment Research)


Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ:CFMS)
Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 39.31%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2017Bradley LangdaleDirectorSell6,722$4.30$28,904.60View SEC Filing  
4/26/2017Daniel SteinesInsiderSell5,000$5.54$27,700.00View SEC Filing  
4/5/2017Daniel SteinesInsiderSell5,000$5.00$25,000.00View SEC Filing  
2/15/2017Philipp LangDirectorSell137,968$8.60$1,186,524.80View SEC Filing  
2/3/2017David CervenyInsiderSell3,569$8.59$30,657.71View SEC Filing  
2/3/2017Paul S WeinerCFOSell2,676$8.42$22,531.92View SEC Filing  
2/3/2017Philipp LangDirectorSell108,705$8.60$934,863.00View SEC Filing  
1/25/2017Philipp LangDirectorSell108,985$8.60$937,271.00View SEC Filing  
1/23/2017Philipp LangDirectorSell9,681$8.60$83,256.60View SEC Filing  
1/13/2017Philipp LangDirectorSell37,275$8.60$320,565.00View SEC Filing  
1/11/2017Philipp LangDirectorSell2,800$8.62$24,136.00View SEC Filing  
1/10/2017Philipp LangDirectorSell83,909$8.64$724,973.76View SEC Filing  
1/9/2017Philipp LangDirectorSell6,200$8.65$53,630.00View SEC Filing  
1/5/2017Philipp LangDirectorSell400$8.60$3,440.00View SEC Filing  
1/3/2017Philipp LangDirectorSell74,876$8.00$599,008.00View SEC Filing  
12/30/2016Philipp LangDirectorSell168,734$8.25$1,392,055.50View SEC Filing  
12/28/2016Philipp LangDirectorSell58,547$8.26$483,598.22View SEC Filing  
12/27/2016Philipp LangDirectorSell42,086$8.57$360,677.02View SEC Filing  
12/23/2016Philipp LangDirectorSell30,647$8.62$264,177.14View SEC Filing  
10/17/2016Daniel SteinesInsiderSell889$8.64$7,680.96View SEC Filing  
10/17/2016Paul S WeinerCFOSell884$8.60$7,602.40View SEC Filing  
10/12/2016Daniel SteinesInsiderSell10,000$9.66$96,600.00View SEC Filing  
10/5/2016Philipp LangCEOSell53,860$10.19$548,833.40View SEC Filing  
10/4/2016Philipp LangCEOSell400$10.00$4,000.00View SEC Filing  
10/3/2016Daniel SteinesCTOSell10,000$10.03$100,300.00View SEC Filing  
10/3/2016Philipp LangCEOSell10,410$10.03$104,412.30View SEC Filing  
9/16/2016Daniel SteinesInsiderSell30,000$9.09$272,700.00View SEC Filing  
8/17/2016Kenneth P Fallon IIIDirectorSell4,000$8.44$33,760.00View SEC Filing  
5/17/2016Robert Law IIISVPBuy1,600$6.20$9,920.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ConforMIS (NASDAQ:CFMS)
Latest Headlines for ConforMIS (NASDAQ:CFMS)
DateHeadline logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - GlobeNewswire (press release) - July 20 at 4:21 AM logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - July 19 at 6:17 PM logoComparing Uroplasty (UPI) & ConforMIS (NASDAQ:CFMS) - July 19 at 9:34 AM logoSt Jude Medical (STJ) versus ConforMIS (CFMS) Head-To-Head Survey - July 19 at 8:51 AM logoBTIG Research Reiterates "Hold" Rating for ConforMIS, Inc. (CFMS) - July 18 at 12:56 AM logoFinancial Comparison: ConforMIS (CFMS) and St Jude Medical (STJ) - July 17 at 2:31 PM logo$19.40 Million in Sales Expected for ConforMIS, Inc. (NASDAQ:CFMS) This Quarter - July 14 at 4:24 PM logoConforMIS, Inc. (CFMS) Rating Increased to Buy at Zacks Investment Research - July 12 at 7:10 PM logoConforMIS Names Dan Krupp Senior Vice President US Sales - GlobeNewswire (press release) - July 12 at 5:42 PM logo Brokerages Expect ConforMIS, Inc. (NASDAQ:CFMS) Will Post Earnings of -$0.36 Per Share - July 12 at 8:30 AM logoZacks Investment Research Lowers ConforMIS, Inc. (CFMS) to Sell - July 11 at 10:52 PM logoETFs with exposure to ConforMIS, Inc. : July 11, 2017 - July 11 at 6:08 PM logoConforMIS Names Dan Krupp Senior Vice President U.S. Sales - July 11 at 6:08 PM logoConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages - July 3 at 10:59 AM logoETFs with exposure to ConforMIS, Inc. : June 26, 2017 - June 26 at 4:56 PM logoRTI Surgical (RTIX) vs. ConforMIS (CFMS) Head to Head Contrast - June 25 at 12:17 PM logoConforMIS, Inc. (CFMS) Director Sells $28,904.60 in Stock - June 22 at 8:16 PM logoConforMIS, Inc. (CFMS) Given "Buy" Rating at Oppenheimer Holdings, Inc. - June 21 at 11:22 PM logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - - June 20 at 9:55 PM logoConforMIS, Inc. (CFMS) Research Coverage Started at BTIG Research - June 20 at 5:30 PM logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - June 20 at 4:53 PM logoConforMIS Announces FDA 510(k) Clearance for iTotal Hip System - June 20 at 4:53 PM logo$19.40 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter - June 18 at 10:00 AM logoConforMIS (CFMS) versus HeartWare International (HTWR) Financial Analysis - June 16 at 10:48 PM logoETFs with exposure to ConforMIS, Inc. : June 16, 2017 - June 16 at 5:00 PM logo Analysts Anticipate ConforMIS, Inc. (CFMS) to Post -$0.36 EPS - June 16 at 8:46 AM logoConforMIS, Inc. :CFMS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 - June 14 at 4:59 PM logoFinancial Comparison: Glaukos Corporation (GKOS) and ConforMIS (CFMS) - June 13 at 10:35 PM logoConforMIS Inc (CFMS) Announces Publication of Study Comparing Customized Knee Replacement Implants to Off-the ... - - June 13 at 3:48 PM logoConforMIS Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement Implants - June 13 at 12:44 PM logoConforMIS Inc (CFMS) Receives Average Recommendation of "Buy" from Analysts - June 6 at 8:42 AM logoAnalyzing RTI Surgical (RTIX) & ConforMIS (CFMS) - June 6 at 12:06 AM logoConforMIS Inc (CFMS) Expected to Announce Earnings of -$0.36 Per Share - May 19 at 1:20 PM logoConforMIS Inc (CFMS) Given "Buy" Rating at B. Riley - May 16 at 6:58 PM logoConforMIS Inc (CFMS) Upgraded by Zacks Investment Research to Hold - May 15 at 10:16 PM logoAnalysts Issue Forecasts for ConforMIS Inc's Q2 2017 Earnings (CFMS) - May 15 at 7:58 AM logoOppenheimer Holdings Comments on ConforMIS Inc's Q2 2017 Earnings (CFMS) - May 15 at 7:58 AM logoConforMIS's (CFMS) "Buy" Rating Reaffirmed at B. Riley - May 14 at 9:36 AM logoConforMIS Inc (CFMS) Given a $8.00 Price Target at Canaccord Genuity - May 13 at 6:58 PM logoConforMIS Inc (CFMS) Receives Average Rating of "Hold" from Brokerages - May 12 at 8:48 AM logoEdited Transcript of CFMS earnings conference call or presentation 10-May-17 8:30pm GMT - May 11 at 9:54 PM logoConforMIS Inc (CFMS) Given a $9.00 Price Target at Oppenheimer Holdings Inc. - May 11 at 2:56 PM logoConforMIS Inc (CFMS) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS - May 11 at 12:44 AM logoConforMIS reports 1Q loss - May 10 at 9:26 PM logoInvestor Network: ConforMIS Inc to Host Earnings Call - May 10 at 4:26 PM logoConforMIS Reports First Quarter 2017 Financial Results - May 10 at 4:26 PM logoConforMIS (CFMS) Getting Somewhat Favorable Press Coverage, Analysis Finds - May 4 at 9:17 AM logoConforMIS (CFMS) Earning Somewhat Negative News Coverage, AlphaOne Reports - May 1 at 4:26 PM logoConforMIS Inc (CFMS) Expected to Announce Quarterly Sales of $18.4 Million - April 30 at 9:16 AM logoConforMIS Inc (CFMS) Insider Daniel Steines Sells 5,000 Shares - April 29 at 1:23 AM



ConforMIS (CFMS) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by Staff